I am a post-doctoral researcher with the METHODS Team at the Centre of Research in Epidemiology and StatisticS (CRESS UMR 1153) in Paris where my work focuses on bringing the “personal” into personalized medicine. Using mixed methods and an interdisciplinary approach, I explore avenues for incorporating patients’ psychosocial and contextual characteristics (“personomics”) into the tailoring of treatment plans.
I was previously postdoctoral fellow with the Cundill Centre for Child and Youth Depression at the Centre for Addiction and Mental Health (CAMH) in Toronto, where I focused on strengthening approaches to outcome measurement in youth mental health, with a focus on functional impairment and the development of core outcome sets.
PhD in Psychology, 2020
University College London
MSc in Political Sociology, 2013
London School of Economics and Political Sciences
BA in Sociology and History, 2010
Georg-August University Goettingen
Key research interests:
Key research interests:
A major barrier to improving care effectiveness for mental health is a lack of consensus on outcomes measurement. The International Consortium for Health Outcomes Measurement (ICHOM) has already developed a consensus-based standard set of outcomes for anxiety and depression in adults (including the Patient Health Questionnaire-9, the Generalised Anxiety Disorder 7-item Scale, and the WHO Disability Schedule). This Position Paper reports on recommendations specifically for anxiety, depression, obsessive-compulsive disorder, and post-traumatic stress disorder in children and young people aged between 6 and 24 years. An international ICHOM working group of 27 clinical, research, and lived experience experts formed a consensus through teleconferences, an exercise using an adapted Delphi technique (a method for reaching group consensus), and iterative anonymous voting, supported by sequential research inputs. A systematic scoping review identified 70 possible outcomes and 107 relevant measurement instruments. Measures were appraised for their feasibility in routine practice (ie, brevity, free availability, validation in children and young people, and language translation) and psychometric performance (ie, validity, reliability, and sensitivity to change). The final standard set recommends tracking symptoms, suicidal thoughts and behaviour, and functioning as a minimum through seven primarily patient-reported outcome measures: the Revised Children’s Anxiety and Depression Scale, the Obsessive Compulsive Inventory for Children, the Children’s Revised Impact of Events Scale, the Columbia Suicide Severity Rating Scale, the KIDSCREEN-10, the Children’s Global Assessment Scale, and the Child Anxiety Life Interference Scale. The set’s recommendations were validated through a feedback survey involving 487 participants across 45 countries. The set should be used alongside the anxiety and depression standard set for adults with clinicians selecting age-appropriate measures.
Book Chapters & Dissertations
Preprints & Working Papers